Back to results
US 2016/0250253 A1Published application
Strontium-containing complexes for treating gastroesophageal reflux and barrett's esophagus
AssigneeCosmederm Bioscience, Inc.
InventorGary S. HAHN
Life of this patent
Estimating the term…
Abstract
Therapeutically-active compositions for treating pain, irritation, and inflammation associated with gastroesophageal reflux and Barrett's esophagus that combines at least one acid neutralizing strontium salt with at least one polyhydroxyphenol, at least one polymer, and optionally at least one cysteine based antioxidant.
Claims26
A composition for treating gastroesophageal reflux comprising:
- (a) at least one acid neutralizing strontium salt selected from the group consisting of:
- strontium carbonate, strontium bicarbonate, strontium hydroxide, strontium phosphate, and strontium citrate;
- (b) at least one polyhydroxyphenol selected from the group consisting of:
- gallic acid, tannic acid, pentagalloyl glucose, ellagic acid, and esters thereof;
- and
- (c) at least one polymer selected from the group consisting of alginic acid, polyvinylpyrrolidone, and xanthan gum.
3 more elements
2-18. (canceled)
A composition for treating gastroesophageal reflux comprising:
- (a) at least one acid neutralizing strontium salt selected from the group consisting of:
- strontium carbonate, strontium bicarbonate, strontium hydroxide, strontium phosphate, and strontium citrate;
- (b) at least one polyhydroxyphenol selected from the group consisting of:
- gallic acid, tannic acid, pentagalloyl glucose, ellagic acid, and esters thereof;
- (c) at least one cysteine based antioxidant selected from the group consisting of cystine and N,S-diacetylcysteine;
- and
- (d) at least one polymer selected from the group consisting of alginic acid, polyvinylpyrrolidone, and xanthan gum.
4 more elements
20-42. (canceled)
45-55. (canceled)
58-61. (canceled)
64-71. (canceled)
74-75. (canceled)
Dependencies are inferred from the claim text.